Antigen-specific immune therapy (CNP-106) for treatment of generalised myasthenia gravis: rationale and design of first-in-human randomised controlled trial von Richard J Nowak, Samantha G Brew, Molly Frey, Derrick P McCarthy, Adam Elhofy

Volltext

US Clinical Practice Experience with Eculizumab in Myasthenia Gravis: Acute Clinical Events and Healthcare Resource Utilization von Richard J. Nowak, Ali A. Habib, Andrew J. Klink, Srikanth Muppidi, Anju Parthan, S. Chloe Sader, Alexandrina Balanean, Ajeet Gajra, James F. Howard, ELEVATE Study Group

Volltext

Application of digital tools and artificial intelligence in the Myasthenia Gravis Core Examination von Marc Garbey, Marc Garbey, Marc Garbey, Quentin Lesport, Quentin Lesport, Helen Girma, Gülşen Öztosun, Mohammed Abu-Rub, Amanda C. Guidon, Vern Juel, Richard J. Nowak, Betty Soliven, Inmaculada Aban, Henry J. Kaminski

Volltext